Carterra

Salt Lake City, United States Founded: 2004 • Age: 22 yrs Acquired By LJI
SPR-based platforms are developed for enzyme kinetics studies.

About Carterra

Carterra is a company based in Salt Lake City (United States) founded in 2004 was acquired by LJI in August 2022. Carterra has raised $47.22 million across 27 funding rounds from investors including HHS, PerkinElmer and LJI. Carterra offers products and services including Carterra Ultra, Carterra LSA XT, and Carterra LSA. Carterra operates in a competitive market with competitors including Nicoya Life, Riot Platforms, FOx Biosystems, Pharma Diagnostics and Plasmore, among others.

  • Headquarter Salt Lake City, United States
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website carterra-bio.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Acquired by LJI (Aug 2022)
  • Legal Name Carterra, Inc.
Key Metrics
  • Total Equity Funding
    $47.22M (USD)

    in 27 rounds

  • Latest Funding Round
    $5M (USD), Series A

    Dec 2023

  • Investors
    HHS

    & 7 more

  • Acquired by
    LJI

    (Aug 2022)

Products & Services of Carterra

Carterra offers a comprehensive portfolio of products and services, including Carterra Ultra, Carterra LSA XT, and Carterra LSA.

Carterra Ultra
SPR Platform

High-sensitivity platform for fragment and small molecule screening in drug discovery.

Carterra LSA XT
Antibody Discovery

Tool for rapid kinetics and weak binder analysis in antibody characterization.

Carterra LSA
High-Throughput Screening

Platform for detailed antibody kinetics and epitope binning processes.

Apps and channels of Carterra

its YouTube channel Carterra has 837 subscribers and 30 videos.

Carterra
YouTube 837 subscribers 30 videos Science & Technology
Open channel

Videos from Carterra

The most watched videos on Carterra's YouTube channel, Carterra (837 subscribers). Click a video to play it here.

High res epitope binning | Antibody screening | High-Throughput Antibody Screening | LSA Platform
2K views
Webinar: Massively Parallel SPR Based Fragment Screening on Ligand Arrays
2K views
Explore Carterra HT-SPR Data | Revvity Informatics Signals VitroVivo | Top Therapeutic Screening
1.5K views
Carterra Biotechnology Innovations | Top Monoclonal Antibody (mAb) Solutions
1.4K views

More on Carterra.

Funding Insights of Carterra

Carterra has successfully raised a total of $47.22M across 27 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $47.22M
  • Total Rounds 27
  • Last Round Series A — $5M
  • Investors Count 7

Latest 10 of 27 funding rounds of Carterra with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2023$5MSeries A––
–
Dec 2020$8.09MSeries A–PerkinElmer
Jan 2020$6MSeries A–Ballast Point Ventures
Aug 2018$4.47MSeries A––
–
Jan 2018$10MSeries A––
Feb 2017$299,999Grant––
Sep 2016$10.3MSeries A––
–
Jul 2016$1.5MGrant––
Jul 2014$225,000Grant––
Jul 2014$2MSeries C––
–
Valuation history

8 investors in total: 8 institutional.

Investors in Carterra

Carterra has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, PerkinElmer and LJI.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital firm focused on life science, medical device and healthcare companies
–thpartners.netSan Francisco, United States
Expansion capital is provided by Ballast Point Ventures to growing companies.
–ballastpointventures.comTampa, United States
Investments are facilitated by Pasadena Angels in Southern California startups.
2000pasadenaangels.comAltadena, United States
-
–frazier.vc-
Medical instruments and supplies are manufactured and provided for healthcare.
1931perkinelmer.comWaltham, United States
Public health and human services are overseen by HHS.
1953hhs.gov-
A government-backed foundation providing seed-stage investments to support small businesses.
1950nsf.govArlington, United States
Immunology research and development services are provided for disease treatments.
1988lji.orgLa Jolla, United States
Premium access

Investor details for Carterra

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Carterra

45 people are tracked at Carterra (14 in leadership, 4 in board & advisors, 27 in team).

NameRoleGroup
Christian Giddens
Director Of SalesLeadership
Andrew Hatch
Director of ResearchLeadership
Steve Chipchase
Chief Production OfficerLeadership
Chris Silva
VP, MarketingLeadership
Chad Hoffmann
VP, Research and DevelopmentLeadership
Rebecca Rich
Director of ScienceLeadership
Janel Fillinger
CFOLeadership
Josh Eckman
CEOLeadership
Tim Germann
Chief Commercial OfficerLeadership
Bruce Gale
Director of ResearchLeadership
Kelly Packard
Director of New Product DevelopmentLeadership
Logan Taylor
Director Of Hardware EngineeringLeadership
Harley Pebley
Director of Software EngineeringLeadership
Chris Morrow
Director of EngineeringLeadership
John Lillig
DirectorBoard & advisors
Joseph D. Keegan
ChairmanBoard & advisors
Alexander Herzick
DirectorBoard & advisors
Jack Ball
DirectorBoard & advisors
Christian Reece
Senior Global Product ManagerTeam
Samuel Smith
Engineering TechnicianTeam

25 more people are available in the full profile.

Premium access

Complete people profiles for Carterra

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Carterra

4 dated milestones of Carterra across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded Carterra is founded.
  2. Funding First funding round.
  3. Exit Acquired by LJI.
  4. Funding Latest funding round, Series A, of $5.0M.

Competitors of Carterra

Carterra operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nicoya Life, Riot Platforms, FOx Biosystems, Pharma Diagnostics and Plasmore, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
nicoyalife.com2012Kitchener, Canada$27.54M–
Hyperspectral optical microscopes for surface analysis are provided.
riotplatforms.com2000Castle Rock, United States–3
Bitcoin mining solutions are offered by the platform.
foxbiosystems.com2017Temse, Belgium$4.53M9
Developer of fiber optic bio-sensing technology based on surface plasmon resonance
pharmadiagnostics.com2007Asse, Belgium$7.4M8
Biomolecular interactions are analyzed via plate-based LSPR assays.
plasmore.com2009Pavia, Italy––
Develops nanoplasmon imaging technology
smartdrop.co.kr2014Seongnam-si, South Korea––
Electronic devices for interface contact angle measurement are provided.
affiniteinstruments.com2015Montreal, Canada––
A portable SPR platform for molecular analysis is developed.
episentum.com2010Upplands Vasby, Sweden––
Label-enhanced surface plasmon resonance biosensors are developed for enhanced detection.
biosensingusa.com2015Tempe, United States––
Surface analytical instruments for life sciences and materials applications
Premium access

Detailed competitors of Carterra

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Carterra

The website of Carterra (carterra-bio.com) receives about 6.4K visits a month.

  • Monthly visits
    6.4K

    ▼ 22.4% vs previous month

Similar websites

Websites whose visitors overlap most with Carterra. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
abdesignlabs.com
100%
4.7K#4,128,811View details
precisionantibody.com
precisionantibody.com
99%
–#3,295,457–
avivasysbio.com
82%
–#1,515,411View details
scytek.com
32%
5.1K#3,738,821View details

Latest news on Carterra

Similar companies to Carterra

10 companies that operate in the same segment as Carterra (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Carterra

Carterra was founded in 2004 and raised its 1st funding round 3 years after it was founded.

Carterra is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.

Carterra is a funded company, having raised a total of $47.22M across 27 funding rounds to date. The company's 1st funding round was a Series C of $2M, raised on Aug 2007.

Carterra develops SPR based platforms to study enzyme kinetics. The company provides users with instruments and services that enable multiplexing on planar array surfaces. It has developed mAb characterization technology called LSA which is used to study epitope bindingmapping, kinetics, and quantitation. It also offers Continuous Flow Microspotter (CFM), which includes an array printing instrument and a microfluidic print head. Its products include spot CFM printhead, which uses a network of microchannels to deposit samples at one time in a block; and CFM instrument, which uses built-in sensors and pumps to control the flow within the CFM print head.

Carterra's top competitors include Nicoya Life, Riot Platforms and FOx Biosystems.

Carterra offers Carterra Ultra, Carterra LSA XT, and Carterra LSA.

Carterra has 8 investors. Key investors include HHS, PerkinElmer, LJI, Pasadena Angels, and Telegraph Hill Partners.

Carterra operates through Carterra, Inc..

Yes. Carterra was acquired by LJI in August 2022.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available